James M Swanson Selected Research

Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)

2/2022	Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD.
1/2021	Lessons From the 1918 Flu Pandemic: A Novel Etiologic Subtype of ADHD?
1/2021	A Qualitative Analysis of Contextual Factors Relevant to Suspected Late-Onset ADHD.
1/2021	The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.
12/2020	Childhood ADHD and Involvement in Early Pregnancy: Mechanisms of Risk.
3/2020	Early substance use in the pathway from childhood attention-deficit/hyperactivity disorder (ADHD) to young adult substance use: Evidence of statistical mediation and substance specificity.
1/2020	Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.
1/2020	Effects of Childhood and Adult Persistent Attention-Deficit/Hyperactivity Disorder on Risk of Motor Vehicle Crashes: Results From the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder.
12/2019	Adult substance use as a function of growth in peer use across adolescence and young adulthood in the context of ADHD: Findings from the MTA.
12/2019	Depression and ADHD-Related Risk for Substance Use in Adolescence and Early Adulthood: Concurrent and Prospective Associations in the MTA.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James M Swanson Research Topics

Disease

95	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2022 - 01/2002
12	Substance-Related Disorders (Drug Abuse) 03/2020 - 08/2007
3	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2006 - 12/2005
2	Headache (Headaches) 05/2006 - 12/2005
1	Growth Disorders 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Conduct Disorder (Conduct Disorders) 03/2020
1	Marijuana Use 03/2020
1	Oppositional Defiant Disorder 03/2020
1	Binge Drinking 04/2016
1	Autistic Disorder (Autism) 01/2016
1	Arthrogryposis 01/2013
1	Contracture 01/2013
1	Opsismodysplasia 01/2013
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2012
1	Mental Disorders (Mental Disorder) 10/2009
1	Sleep Deprivation 05/2009
1	Tic Disorders (Tic Disorder) 06/2006
1	Weight Loss (Weight Reduction) 05/2006
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2006
1	Dyskinesias (Dyskinesia) 02/2000
1	Tardive Dyskinesia 02/2000

Drug/Important Bio-Agent (IBA)

36	Pemetrexed (MTA)FDA Link 02/2022 - 05/2002
27	Methylphenidate (Ritalin)FDA LinkGeneric 10/2018 - 03/2002
15	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 02/2000
9	Pharmaceutical PreparationsIBA 03/2020 - 03/2002
6	Modafinil (Provigil)FDA Link 05/2006 - 01/2003
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018 - 02/2007
4	TabletsIBA 05/2006 - 12/2005
3	Illicit Drugs (Recreational Drugs)IBA 03/2020 - 01/2018
3	Cocaine (Cocaine HCl)IBA 01/2018 - 02/2007
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2017 - 01/2002
3	AdderallIBA 10/2003 - 06/2003
2	CatecholaminesIBA 01/2021 - 05/2003
2	Biological ProductsIBA 11/2018 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 10/2007
2	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 11/2013 - 06/2006
2	RacloprideIBA 05/2009 - 08/2007
2	SLI381IBA 06/2003 - 06/2003
2	Amphetamine (Amfetamine)FDA LinkGeneric 06/2003 - 06/2003
1	TEMPOIBA 01/2022
1	Nicotine FDA Link 04/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	trans-sodium crocetinate (crocetin)IBA 12/2015
1	Contractile ProteinsIBA 01/2013
1	Inositol (Myoinositol)IBA 01/2013
1	Phosphates (Orthophosphate)IBA 01/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2013
1	PolyphosphatesIBA 01/2013
1	Central Nervous System StimulantsIBA 01/2010
1	Complement System Proteins (Complement)IBA 10/2009
1	LigandsIBA 09/2009
1	CarbonIBA 08/2007
1	Pemoline (Cylert)FDA Link 06/2006
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2006
1	Dexmethylphenidate Hydrochloride FDA LinkGeneric 11/2004
1	Therapeutic UsesIBA 11/2003
1	SaltsIBA 06/2003
1	Delayed-Action PreparationsIBA 06/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2003
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2003
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2003
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2003
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2000
1	Antipsychotic Agents (Antipsychotics)IBA 02/2000
1	Haloperidol (Haldol)FDA LinkGeneric 02/2000

Therapy/Procedure

47	Combined Modality Therapy 02/2022 - 05/2002
2	Drug Therapy (Chemotherapy) 06/2006 - 01/2003
1	Treatment Delay 01/2021
1	Aftercare (After-Treatment) 05/2009
1	Therapeutics 01/2003